LATE BREAKING ABSTRACT: A Phase 1 dose escalation, safety, and pharmacokinetic study of PF-06650808, an anti-Notch3 antibody drug conjugate, in adul...

Date 27 September 2015
Event European Cancer Congress 2015
Session Early Drug Development II
Topics Drug Development
Presenter Rosen, L.